Nutritional interventions to prevent retinopathy of prematurity

Ann Hellström,Elsa Kermorvant-Duchemin,Mark Johnson,Miguel Sáenz de Pipaón,Lois E. Smith,Anna-Lena Hård,Christoph Fusch,Silvia Iacobelli,Mark J. Johnson,Alexandre Lapillonne,Sissel J. Moltu,Miguel Sáenz de Pipaón,Gitte Zachariassen

DOI: https://doi.org/10.1038/s41390-024-03208-1

IF: 3.953

2024-04-30

Pediatric Research

Abstract:Very preterm infants are at high risk of growth failure. Poor weight gain is a prominent risk factor for retinopathy of prematurity (ROP) and optimizing nutrition could potentially promote growth and reduce ROP. Most infants at risk of ROP need parenteral nutrition initially and studies of enhanced parenteral provision of lipids and amino acids have suggested a beneficial effect on ROP. Higher amino acid intake was associated with lower incidence of hyperglycemia, a risk factor for ROP. For very preterm infants, providing unpasteurized fortified raw maternal breast milk appears to have a dose-dependent preventive effect on ROP. These infants become deficient in arachidonic acid (ArA) and docosahexaenoic acid (DHA) after birth when the maternal supply is lost. Earlier studies have investigated the impact of omega-3 fatty acids on ROP with mixed results. In a recent study, early enteral supplementation of ArA 100 mg/kg/d and DHA 50 mg/kg/d until term equivalent age reduced the incidence of severe ROP by 50%.

pediatrics